A single downstream gene is unable to reverse complex diseases of aging.

Transcription factors are upstream “manager” genes that can return aged, diseased cells to health.

Junevity's founders spent six years at UCSF creating a next-generation approach
to rejuvenation.

Junevity invented a new discovery platform to identify novel targets to treat age-related diseases.

REWIND builds on innovations in genomics, machine learning, CRISPR, and aging biology.